1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 2, 2000
ENCORE MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 0-26538 65-0572565
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
9800 Metric Blvd., Austin, Texas 78758
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (512) 832-9500
2
ITEM 5. APPOINTMENT OF NEW CHIEF EXECUTIVE OFFICER AND PRESIDENT.
Effective October 2, 2000, Encore Medical Corporation announced that it
has hired Kenneth Davidson as Chief Executive Officer and President. Nick
Cindrich, current CEO will remain as Chairman of the Board of Encore Medical
Corporation. Craig Smith will remain as President of Encore Orthopedics, Inc.
ITEM 7. EXHIBITS.
The following is a list of exhibits filed as part of this Current
Report on Form 8-K:
Exhibit No. Description
99.1 Press Release issued October 2, 2000
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ENCORE MEDICAL CORPORATION
Date: October 3, 2000 By: /s/ Nick Cindrich
----------------------------
Nick Cindrich, Chairman of the Board
-2-
3
INDEX TO EXHIBITS
Exhibit
Number Description
- -------- -----------
99.1 Press Release issued October 2, 2000